Lexeo Therapeutics, Inc. · NASDAQ:LXEO
D1 Capital Partners L.P.'s stake in Lexeo Therapeutics, Inc. fell to 2.90% (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 15, 2025
D1 Capital Partners L.P.'s stake in Lexeo Therapeutics, Inc. fell to 2.90%, 978,652 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).
- Stake
- 2.90%
- Shares
- 978,652
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| D1 Capital Partners L.P. | 2.90% | 978,652 |
| Daniel Sundheim | 2.90% | 978,652 |
Source
Related
- Lexeo Therapeutics, Inc.
- D1 Capital Partners L.P.
- Lexeo Therapeutics, Inc. shareholders
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Bhalla Narinder Pal · Sep 28, 2026
- Form 4 · Otero Jose Manuel · Sep 28, 2026
- Form 4 · Townsend Richard Nolan · Sep 28, 2026
- Form 4 · Tamayo Louis Edward · Aug 19, 2026